Bi-wen Yeh
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Empagliflozin attenuates sorafenib-promoted renal ferroptosis and inflammation by targeting cyclooxygenase-2/prostaglandin E2 axis.
Journal: Toxicology and applied pharmacology
Published: June 29, 2025
Phenolic zingerone nanoparticles impede cell cycle progression to compete against human urothelial carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 20, 2025
Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 17, 2024
Excavatolide C/cisplatin combination induces antiproliferation and drives apoptosis and DNA damage in bladder cancer cells.
Journal: Archives of toxicology
Published: August 29, 2023
The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 21, 2023
Withaferin A Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress.
Withaferin A Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress.
Journal: Antioxidants (Basel, Switzerland)
Published: June 07, 2021
Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma.
Journal: Journal of clinical medicine
Published: March 27, 2020
The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy.
Journal: Toxicology and applied pharmacology
Published: January 21, 2020
Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy.
Journal: World journal of urology
Published: January 12, 2020
Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.
Journal: Cells
Published: October 15, 2019
Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
Journal: Theranostics
Published: August 04, 2019
Last Updated: 09/26/2026